AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India flag India · Delayed Price · Currency is INR
6,951.50
-155.00 (-2.18%)
Aug 31, 2026, 3:30 PM IST

AstraZeneca Pharma India Company Description

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.

It provides medicines for cancers, including pancreatic cancer, certain blood cancers, and cancers within breast, lung, ovary, and prostate; rare diseases; and cardiovascular, renal and metabolism, and respiratory and immunology, as well as diabetes.

The company serves distributors, hospitals, and government institutions. The company was incorporated in 1979 and is based in Bengaluru, India.

AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

AstraZeneca Pharma India Limited
CountryIndia
Founded1979
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees600
CEOPraveen Akkinepally

Contact Details

Address:
Manyata Embassy Business Park
Bengaluru, 560045
India
Phone91 80 6774 8000
Websiteastrazeneca.in

Stock Details

Ticker SymbolASTRAZEN
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE203A01020
SIC Code2834

Key Executives

NamePosition
Praveen Rao AkkinepallyMD, Country President and Executive Director
Bhavana AgrawalWhole-Time Executive Director and Chief Financial Officer
Tanya SanishCompany Secretary and Compliance Officer
Sandhya Amanna TejaswiniDirector of Legal
Smita SahaVice President of Human Resources
Ayush Kumar AgarwalBusiness Unit Head of Biopharmaceutical Business Unit
Vinay SharmaBusiness Unit Head of Rare Disease unit
Natarajan VenkatakrishnanHead of Market Access
Amarpreet Kaur AhujaCountry Human Resources Director
Srikanth B. S.Site Lead, India Operations